Early outcomes after lung transplantation for severe COVID-19: a series of the first consecutive cases from four countries
Ankit Bharat, Tiago N Machuca, Melissa Querrey, Chitaru Kurihara, Rafael Garza-Castillon Jr, Samuel Kim, Adwaiy Manerikar, Andres Pelaez, Mauricio Pipkin, Abbas Shahmohammadi, Mindaugas Rackauskas, Suresh Rao Kg, K R Balakrishnan, Apar Jindal, Lara Schaheen, Samad Hashimi, Bhuvin Buddhdev, Ashwini Arjuna, Lorenzo Rosso, Alessandro Palleschi, Christian Lang, Peter Jaksch, G R Scott Budinger, Mario Nosotti, Konrad Hoetzenecker, Ankit Bharat, Tiago N Machuca, Melissa Querrey, Chitaru Kurihara, Rafael Garza-Castillon Jr, Samuel Kim, Adwaiy Manerikar, Andres Pelaez, Mauricio Pipkin, Abbas Shahmohammadi, Mindaugas Rackauskas, Suresh Rao Kg, K R Balakrishnan, Apar Jindal, Lara Schaheen, Samad Hashimi, Bhuvin Buddhdev, Ashwini Arjuna, Lorenzo Rosso, Alessandro Palleschi, Christian Lang, Peter Jaksch, G R Scott Budinger, Mario Nosotti, Konrad Hoetzenecker
Abstract
Background: Lung transplantation is a life-saving treatment for patients with end-stage lung disease; however, it is infrequently considered for patients with acute respiratory distress syndrome (ARDS) attributable to infectious causes. We aimed to describe the course of disease and early post-transplantation outcomes in critically ill patients with COVID-19 who failed to show lung recovery despite optimal medical management and were deemed to be at imminent risk of dying due to pulmonary complications.
Methods: We established a multi-institutional case series that included the first consecutive transplants for severe COVID-19-associated ARDS known to us in the USA, Italy, Austria, and India. De-identified data from participating centres-including information relating to patient demographics and pre-COVID-19 characteristics, pretransplantation disease course, perioperative challenges, pathology of explanted lungs, and post-transplantation outcomes-were collected by Northwestern University (Chicago, IL, USA) and analysed.
Findings: Between May 1 and Sept 30, 2020, 12 patients with COVID-19-associated ARDS underwent bilateral lung transplantation at six high-volume transplant centres in the USA (eight recipients at three centres), Italy (two recipients at one centre), Austria (one recipient), and India (one recipient). The median age of recipients was 48 years (IQR 41-51); three of the 12 patients were female. Chest imaging before transplantation showed severe lung damage that did not improve despite prolonged mechanical ventilation and extracorporeal membrane oxygenation. The lung transplant procedure was technically challenging, with severe pleural adhesions, hilar lymphadenopathy, and increased intraoperative transfusion requirements. Pathology of the explanted lungs showed extensive, ongoing acute lung injury with features of lung fibrosis. There was no recurrence of SARS-CoV-2 in the allografts. All patients with COVID-19 could be weaned off extracorporeal support and showed short-term survival similar to that of transplant recipients without COVID-19.
Interpretation: The findings from our report show that lung transplantation is the only option for survival in some patients with severe, unresolving COVID-19-associated ARDS, and that the procedure can be done successfully, with good early post-transplantation outcomes, in carefully selected patients.
Funding: National Institutes of Health. VIDEO ABSTRACT.
Conflict of interest statement
Declaration of interests We declare no competing interests.
Copyright © 2021 Elsevier Ltd. All rights reserved.
Figures
![Figure 1](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/8012035/bin/gr1_lrg.jpg)
![Figure 2](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/8012035/bin/gr2_lrg.jpg)
![Figure 3](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/8012035/bin/gr3_lrg.jpg)
References
- van der Mark SC, Hoek RAS, Hellemons ME. Developments in lung transplantation over the past decade. Eur Respir Rev. 2020;29
- Lang C, Jaksch P, Hoda MA. Lung transplantation for COVID-19-associated acute respiratory distress syndrome in a PCR-positive patient. Lancet Respir Med. 2020;8:1057–1060.
- Han W, Zhu M, Chen J. Lung transplantation for elderly patients with end-stage COVID-19 pneumonia. Ann Surg. 2020;272:e33–e34.
- Chen JY, Qiao K, Liu F. Lung transplantation as therapeutic option in acute respiratory distress syndrome for coronavirus disease 2019-related pulmonary fibrosis. Chin Med J. 2020;133:1390–1396.
- Geleris J, Sun Y, Platt J. Observational study of hydroxychloroquine in hospitalized patients with COVID-19. N Engl J Med. 2020;382:2411–2418.
- Richardson S, Hirsch JS, Narasimhan M. Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City area. JAMA. 2020;323:2052–2059.
- Horby P, Lim WS, Emberson JR. Dexamethasone in hospitalized patients with COVID-19—preliminary report. N Engl J Med. 2020 doi: 10.1056/NEJMoa2021436. published online July 20.
- Beigel JH, Tomashek KM, Dodd LE. Remdesivir for the treatment of COVID-19—preliminary report. Reply. N Engl J Med. 2020;383:994.
- Weill D, Benden C, Corris PA, et al. A consensus document for the selection of lung transplant candidates: 2014—an update from the pulmonary transplantation council of the international society for heart and lung transplantation. J Heart Lung Transplant34: 1–15.
- Bharat A, Querrey M, Markov NS. Lung transplantation for patients with severe COVID-19. Sci Transl Med. 2020;12
- Lang C, Jaksch P, Hoda MA. Lung transplantation for COVID-19-associated acute respiratory distress syndrome in a PCR-positive patient. Lancet Respir Med. 2020;8:1057–1060.
- Brower RG, Lanken PN, MacIntyre N. Higher versus lower positive end-expiratory pressures in patients with the acute respiratory distress syndrome. N Engl J Med. 2004;351:327–336.
- Orens JB, Boehler A, de Perrot M. A review of lung transplant donor acceptability criteria. J Heart Lung Transplant. 2003;22:1183–1200.
- Oto T, Levvey BJ, Whitford H. Feasibility and utility of a lung donor score: correlation with early post-transplant outcomes. Ann Thorac Surg. 2007;83:257–263.
- De Jonghe B, Sharshar T, Lefaucheur JP. Paresis acquired in the intensive care unit: a prospective multicenter study. JAMA. 2002;288:2859–2867.
- Chang Y, Lee SO, Shim TS. Lung transplantation as a therapeutic option in acute respiratory distress syndrome. Transplantation. 2018;102:829–837.
- Botta M, Tsonas AM, Pillay J. Ventilation management and clinical outcomes in invasively ventilated patients with COVID-19 (PRoVENT-COVID): a national, multicentre, observational cohort study. Lancet Respir Med. 2020;9:139–148.
- Wölfel R, Corman VM, Guggemos W. Virological assessment of hospitalized patients with COVID-2019. Nature. 2020;581:465–469.
- Arons MM, Hatfield KM, Reddy SC. Presymptomatic SARS-CoV-2 infections and transmission in a skilled nursing facility. N Engl J Med. 2020;382:2081–2090.
- Bullard J, Dust K, Funk D. Predicting infectious SARS-CoV-2 from diagnostic samples. Clin Infect Dis. 2020 doi: 10.1093/cid/ciaa638. published May 22.
- Benazzo A, Schwarz S, Frommlet F. Twenty-year experience with extracorporeal life support as bridge to lung transplantation. J Thorac Cardiovasc Surg. 2019;157:2515–2525.
- Hoetzenecker K, Donahoe L, Yeung JC. Extracorporeal life support as a bridge to lung transplantation-experience of a high-volume transplant center. J Thorac Cardiovasc Surg. 2018;155:1316–1328.
- Levine S, Nguyen T, Taylor N. Rapid disuse atrophy of diaphragm fibers in mechanically ventilated humans. N Engl J Med. 2008;358:1327–1335.
- Jiritano F, Serraino GF, Ten Cate H. Platelets and extra-corporeal membrane oxygenation in adult patients: a systematic review and meta-analysis. Intensive Care Med. 2020;46:1154–1169.
- Herridge MS, Tansey CM, Matté A. Functional disability 5 years after acute respiratory distress syndrome. N Engl J Med. 2011;364:1293–1304.
- Grant RA, Morales-Nebreda L, Markov NS. Circuits between infected macrophages and T cells in SARS-CoV-2 pneumonia. Nature. 2021 doi: 10.1038/S41586-020-03148-W. published online Jan 21.
- Gupta RK, Marks M, Samuels THA. Systematic evaluation and external validation of 22 prognostic models among hospitalised adults with COVID-19: an observational cohort study. Eur Respir J. 2020;56
- Mushtaq J, Pennella R, Lavalle S. Initial chest radiographs and artificial intelligence (AI) predict clinical outcomes in COVID-19 patients: analysis of 697 Italian patients. Eur Radiol. 2020 doi: 10.1007/S00330-020-07269-8. published online Sept 18.
- Giani M, Seminati D, Lucchini A, Foti G, Pagni F. Exuberant plasmocytosis in bronchoalveolar lavage specimen of the first patient requiring extracorporeal membrane oxygenation for SARS-CoV-2 in Europe. J Thorac Oncol. 2020;15:e65–e66.
Source: PubMed